The SWOG YITC is noted as one of the top educational intensives for new researchers in cancer clinical trials, providing one-on-one mentorship by the expert faculty of SWOG, including the Group Chair and Executive Officers. The course is three full days of protocol development, trial management, and statistical analysis – topics identified by seasoned and new researchers alike as areas of specific concern to those entering the field.
The 2017 application window is now closed. The SWOG Leadership Academy engages the best and brightest of the Group’s early career investigators to prepare them for future leadership within the National Clinical Trials Network (NCTN). This three-year program provides long-term mentorship and training in the organizational structure of SWOG and the NCTN, resources available through the NCI and […]
SWOG Virtual Grant Writing Workshop February – April, 2017 Grants underlie most cancer research. Increased competition for fewer resources means the success rate for federal grant applications has dropped significantly. This drop is especially worrisome when we think about what it means for our younger investigators, who are trying to build a successful research career. […]
Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). These awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis […]
Awards Supporting Activated SWOG Cancer Clinical Trials The Hope Foundation and SWOG have established the SWOG Trial Support (STrS) program to ensure that outstanding proposals don’t languish for lack of financing. STrS is designed to support trial components that need supplemental funding during patient enrollment in a SWOG study. Qualifying components may include things that […]
The Integrated Translational Science Center (ITSC) is a partnership between SWOG, Cold Spring Harbor Laboratory (CSHL) and The Jackson Laboratory (JAX) with the goal of facilitating incorporation of translational science into NCTN clinical trials. The program funds an annual workshop as well as pilot grants. SWOG/ITSC Pilot Grants The purpose of the SWOG ITSC Pilot […]
The primary purpose of the Dr. Charles A. Coltman, Jr., Fellowship is to engage outstanding young investigators from SWOG affiliated institutions in learning clinical trial methodology within an academic and cooperative group environment that will lead to independent clinical research, while honoring the legacy of long-time SWOG Chair and leader, Dr. Charles Coltman.
SWOG is committed to providing patients within the VA Health Administration system access to cutting-edge cancer clinical trials and treatments throughout the National Cancer Institute’s National Clinical Trials Network (NCTN). We facilitate that process by allowing veterans to participate in life‐changing therapies through clinical research. Awards from the SWOG/Hope Foundation VA Integration Support Program support Veterans Health Administration Medical […]
SWOG/Hope Foundation Impact Awards provide a mechanism for the cancer research community to participate with SWOG in translating scientific discovery to patient care, and are intended to encourage innovative approaches to the conduct of clinical investigation. Individual projects are funded for up to $250,000 in total costs.
The objective of the SWOG/Hope Rare Cancer Fellowship is to provide protected time via salary support for a clinical investigator who is committed to strengthening SWOG’s progress and trial portfolio in rare cancer. Working within SWOG’s Early Therapeutics and Rare Cancer (ET/RC) Committee, and with assistance from the ET/RC Committee Chair, the Rare Cancer Fellow […]
The Hope Foundation/SWOG Secondary Data Analysis Central to SWOG’s research mission is Cancer Care Delivery Research conducted through the Group’s CCDR committee, whose aim is to improve the quality of cancer care and reduce healthcare disparities through clinical, epidemiologic, and translational research, with the ultimate goal of improving cancer outcomes. The Hope Foundation’s Secondary Data […]